Wuhan Keqian Biology Co.,Ltd (688526.SS)
CNY 14.62
(-0.27%)
CNY 14.62
(-0.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -288.23 Million CNY | -63.22% |
| 2022 | -176.58 Million CNY | 63.0% |
| 2021 | -477.26 Million CNY | 74.26% |
| 2020 | -1.85 Billion CNY | -176.27% |
| 2019 | -671.04 Million CNY | -9.89% |
| 2018 | -610.63 Million CNY | -981.01% |
| 2017 | -56.48 Million CNY | 78.95% |
| 2016 | -268.33 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -608.36 Million CNY | -111.07% |
| 2024 Q3 | -341.11 Million CNY | 22.45% |
| 2024 Q2 | -432.81 Million CNY | 28.86% |
| 2023 Q1 | -329.96 Million CNY | -86.85% |
| 2023 FY | -288.23 Million CNY | -63.22% |
| 2023 Q2 | -93.12 Million CNY | 71.78% |
| 2023 Q4 | -288.23 Million CNY | 23.44% |
| 2023 Q3 | -376.49 Million CNY | -304.29% |
| 2022 Q4 | -176.58 Million CNY | 54.22% |
| 2022 Q3 | -385.75 Million CNY | 33.18% |
| 2022 Q2 | -577.26 Million CNY | -16.18% |
| 2022 Q1 | -496.85 Million CNY | -4.1% |
| 2022 FY | -176.58 Million CNY | 63.0% |
| 2021 Q4 | -477.26 Million CNY | 75.46% |
| 2021 Q3 | -1.94 Billion CNY | -4.55% |
| 2021 Q2 | -1.86 Billion CNY | 11.31% |
| 2021 Q1 | -2.09 Billion CNY | -13.15% |
| 2021 FY | -477.26 Million CNY | 74.26% |
| 2020 Q3 | -1.81 Billion CNY | -155.28% |
| 2020 FY | -1.85 Billion CNY | -176.27% |
| 2020 Q4 | -1.85 Billion CNY | -1.89% |
| 2020 Q2 | -712.74 Million CNY | -206.21% |
| 2020 Q1 | 671.04 Million CNY | 200.0% |
| 2019 Q1 | 720.63 Million CNY | 0.0% |
| 2019 Q4 | -671.04 Million CNY | 0.0% |
| 2019 Q2 | -639.63 Million CNY | -188.76% |
| 2019 FY | -671.04 Million CNY | -9.89% |
| 2018 FY | -610.63 Million CNY | -981.01% |
| 2017 FY | -56.48 Million CNY | 78.95% |
| 2016 FY | -268.33 Million CNY | 0.0% |